Colloidal pectin bismuth capsule
Approval date: 16 March 2007
Modified date: 01 October 2010
November 30, 2015
Instructions for colloidal pectin bismuth capsules
Please read the instructions carefully and use them under the guidance of your physician.
[name of drug]
General name: colloidal pectin bismuth capsule
Colloidal Bismuth Pectin Capsules
Chinese phonetic alphabet: Jiaoti Guojiaobi Jiaonang
The main ingredient of this product is: colloidal pectin bismuth, which is an indeterminate compound formed by pectin and bismuth.
[properties] this product is capsule, the content is yellow particles or powder.
[indications] this product is suitable for treating peptic ulcer, especially helicobacter pylori related ulcer, and also for chronic superficial gastritis and atrophic gastritis.
[specification] 50mg in Bi
[usage and dosage] oral. A time of 100mg ~ 150mg (2 ~ 3 pills), 4 times a day, take 1 hour before 3 meals and before sleeping respectively, four weeks for a course of treatment.
[adverse reactions] gastrointestinal symptoms such as nausea and constipation may occur occasionally.
[contraindication] this product is contraindicated for allergy and renal insufficiency.
(1) if the symptoms are not relieved or disappear after continuous use of this product for one course of treatment, please consult a doctor.
(2) it is normal to have black, brown and lustrous stools without other discomfort during taking the medicine. After 1 ~ 2 days after drug withdrawal, the color of feces can be changed to normal.
(3) do not take other bismuth preparations during taking this product, and do not take large doses of this product for a long time.
[drugs for pregnant and lactating women] pregnant women are forbidden. Nursing women should stop breastfeeding when using this product.
[medication for children] is not clear.
[geriatric medication] is not clear.
[drug interaction] this product should not be taken together with acid-making drugs, milk and H2 receptor blockers, otherwise the efficacy will be reduced.
[drug overdose] if the product is taken in large doses for a long time, bismuth poisoning will occur, and the skin will be dark brown, so the drug should be stopped immediately and treated appropriately.
[pharmacology and toxicology] this product is for gastrointestinal mucosa protection. After oral administration, a sol is formed in the stomach, which has a strong affinity with the ulcer surface and the inflammatory surface, and can form an effective protective film, isolate gastric acid, protect the damaged mucosa, stimulate the secretion of mucus by gastrointestinal mucosal epithelial cells, and promote the repair of epithelial cells themselves. Good adhesion to damaged mucous membrane. This product can kill helicobacter pylori.
[pharmacokinetics] after oral administration of this product, the absorption in the intestinal tract is very small, the blood drug concentration and urine drug concentration is very low, most of the product with feces out of the body. Trace bismuth is mainly distributed in liver, kidney and other tissues after absorption. [storage] shading, sealed (10 ~ 30℃) storage.
[packaging] aluminum and plastic packaging, 12 pieces per box; 24 pills per box.
[validity period] 24 months
[executive standard] the second edition of Chinese pharmacopoeia in 2015
[approval document no.] sinopharma approval number H20059181
Company name: guangdong peidi pharmaceutical co., LTD
Production address: 66 peidi avenue, yueshan town, kaiping city, guangdong province
Telephone number :(0750)2789348 2783621
400-8899-328 (national service telephone number)
Fax number :(0750)2789348